Patents by Inventor Veronique Grenier-Caussanel

Veronique Grenier-Caussanel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CXCR4 antibodies and their use for the treatment of cancer
    Patent number: 9388248
    Abstract: The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: July 12, 2016
    Assignee: Pierre Fabre Medicament
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Veronique Grenier-Caussanel
  • Humanized anti CXCR4 antibodies for the treatment of cancer
    Patent number: 9249223
    Abstract: The present invention relates to a novel isolated humanized antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to hz515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: February 2, 2016
    Assignee: Pierre Fabre Medicament
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Véronique Grenier-Caussanel
  • NOVEL ANTI-CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
    Publication number: 20140050661
    Abstract: The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Application
    Filed: September 13, 2013
    Publication date: February 20, 2014
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Christine KLINGUER-HAMOUR, Alexandra Jouhanneaud, Veronique Grenier-Caussanel
  • Anti CXCR4 antibodies and their use for the treatment of cancer
    Patent number: 8557964
    Abstract: The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: October 15, 2013
    Assignee: Pierre Fabre Medicament
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Véronique Grenier-Caussanel
  • HUMANIZED ANTI CXCR4 ANTIBODIES FOR THE TREATMENT OF CANCER
    Publication number: 20130031647
    Abstract: The present invention relates to a novel isolated humanized antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to hz515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Application
    Filed: March 30, 2011
    Publication date: January 31, 2013
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Véronique Grenier-Caussanel
  • NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
    Publication number: 20110294156
    Abstract: The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Application
    Filed: June 23, 2011
    Publication date: December 1, 2011
    Inventors: Christine KLINGUER-HAMOUR, Alexandra Jouhanneaud, Véronique Grenier-Caussanel
  • NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
    Publication number: 20110287451
    Abstract: The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Application
    Filed: June 23, 2011
    Publication date: November 24, 2011
    Inventors: Christine KLINGUER-HAMOUR, Alexandra Jouhanneaud, Veronique Grenier-Caussanel
  • NOVEL ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
    Publication number: 20110020218
    Abstract: The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
    Type: Application
    Filed: March 30, 2010
    Publication date: January 27, 2011
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Véronique Grenier-Caussanel